Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
- Key market highlights
PART 05: Botulinum toxin: An overview
PART 06: Pipeline landscape
PART 07: Market landscape
- Five forces analysis
PART 08: Market segmentation by drug categories
- Aesthetic drugs market
- Therapeutic drugs market
PART 09: Geographical segmentation
- Botulinum toxin market in Americas
- Botulinum toxin market in EMEA
- Botulinum toxin market in APAC
PART 10: Decision framework
PART 11: Drivers and challenges
- Market drivers
- Impact of drivers on key customer segments
- Market challenges
- Impact of challenges on key customer segments
PART 12: Market trends
- Growing importance of medical aesthetics
- Technological advancement
- Growing demand for anti-aging treatment
PART 13: Vendor landscape
- Competitive landscape
- Key news
PART 14: Key vendor analysis
- ALLERGAN
- Galderma
- Ipsen
- Merz Pharma
- Pfizer
- Other prominent vendors
PART 15: Appendix
- List of abbreviations

List of Exhibits
Exhibit 01: Pipeline landscape
Exhibit 02: Global botulinum toxin market: Snapshot
Exhibit 03: Global botulinum toxin market 2016-2021 ($ millions)
Exhibit 04: Global botulinum toxin market: Opportunity analysis
Exhibit 05: Five forces analysis
Exhibit 06: Market segmentation by drug category 2016
Exhibit 07: Global aesthetic drugs market 2016-2021 ($ millions)
Exhibit 08: Global therapeutic drugs market 2016-2021 ($ millions)
Exhibit 09: Segmentation of global botulinum toxin market based on geography 2016 and 2021
Exhibit 10: Global botulinum toxin market revenue by geography 2016-2021 ($ millions)
Exhibit 11: Market scenario in Americas
Exhibit 12: Botulinum toxin market in Americas 2016-2021 ($ millions)
Exhibit 13: Market scenario in EMEA
Exhibit 14: Botulinum toxin market in EMEA 2016-2021 ($ millions)
Exhibit 15: Market scenario in APAC
Exhibit 16: Botulinum toxin market in APAC 2016-2021 ($ millions)
Exhibit 17: Key R&D-based growth drivers
Exhibit 18: Impact of drivers
Exhibit 19: Impact of challenges
Exhibit 20: Top five non-surgical procedures (injectable) of 2015
Exhibit 21: Competitive structure analysis of global botulinum toxin market 2016
Exhibit 22: Competitive analysis of global botulinum toxin market 2016
Exhibit 23: Global market penetration of players in botulinum toxin market 2016
Exhibit 24: ALLERGAN: Key highlights
Exhibit 25: ALLERGAN: Strength assessment
Exhibit 26: ALLERGAN: Strategy assessment
Exhibit 27: ALLERGAN: Opportunity assessment
Exhibit 28: Galderma: Key highlights
Exhibit 29: Galderma: Strength assessment
Exhibit 30: Galderma: Strategy assessment
Exhibit 31: Galderma: Opportunity assessment
Exhibit 32: Ipsen: Key highlights
Exhibit 33: Ipsen: Strength assessment
Exhibit 34: Ipsen: Strategy assessment
Exhibit 35: Ipsen: Opportunity assessment
Exhibit 36: Merz Pharma: Key highlights
Exhibit 37: Merz Pharma: Strength assessment
Exhibit 38: Merz Pharma: Strategy assessment
Exhibit 39: Merz Pharma: Opportunity assessment
Exhibit 40: Pfizer: Strength assessment
Exhibit 41: Pfizer: Strategy assessment
Exhibit 42: Pfizer: Opportunity assessment

Companies Mentioned
- ALLERGAN
- Galderma
- Ipsen
- Merz Pharma
- Pfizer
- Acorda Therapeutics
- Aldeyra Therapeutics
- Azidus Brasil
- Biolab Sanus Farmaceutica
- Canbex Therapeutics
- DAEWOONG
- Emcure Pharmaceuticals
- Endo Pharmaceuticals International
- Evolus
- Fresenius Kabi
- GlaxoSmithKline
- INSYS THERAPEUTICS
- Johnson & Johnson
- Lannett
- Lanzhou Institute of Biological Products
- LEO Pharma
- Mylan
- Par Pharmaceuticals
- PhytoTech Therapeutics
- Revance Therapeutics
- Sun Pharmaceuticals
- Takeda Pharmaceutical
- UroGen Pharma.